Document:

EX-10.30

 Exhibit 10.30 
 [Execution Copy] 
 MANAGEMENT UNIT SUBSCRIPTION AGREEMENT 

(Class A-2 Units and Class B Units) 
 THIS MANAGEMENT UNIT SUBSCRIPTION AGREEMENT (this “Agreement”) by and between Apria Holdings LLC, a Delaware limited liability company (the “Company”), and the individual
named on the Executive Master Signature Page hereto (“Executive”) is made as of the date set forth on such Executive Master Signature Page. 
 WHEREAS, on the terms and subject to the conditions hereof, Executive desires to subscribe for and acquire from the Company, and the Company desires to issue and provide to Executive, the Company’s
Class A-2 Units and Class B Units (the “Units”), in each case in the amount set forth on Executive’s Master Signature Page, as hereinafter set forth; and 

WHEREAS, this Agreement is one of several agreements being entered into by the Company or its Subsidiaries with certain persons who are
or will be key employees or advisors of the Company or one or more Affiliates (collectively with Executive, the “Management Investors”) as part of a management equity purchase plan designed to comply with Regulation D or Rule 701,
as applicable, promulgated under the Securities Act (as defined below); 
 NOW, THEREFORE, in order to implement the foregoing
and in consideration of the mutual representations, warranties, covenants and agreements contained herein, the parties hereto agree as follows: 
  

	1.	Definitions. 

 1.1
Affiliate. An “Affiliate” of, or Person “Affiliated” with, a specified Person shall mean a Person that directly, or indirectly through one or more intermediaries or contractual counterparties, controls or is
controlled by, or is under common control with, the Person specified. 
 1.2 Agreement. The term “Agreement”
shall have the meaning set forth in the preface. 
 1.3 Blackstone. The term “Blackstone” means Blackstone
Capital Partners V L.P. and its Affiliates. 
 1.4 Board. The “Board” shall mean the Company’s Board of
Directors. 

  
 1 

 1.5 Cause. The term “Cause” shall have the meaning assigned such term in
Executive’s employment agreement (the “Employment Agreement”) with Apria Healthcare Group Inc. (“Apria”) dated as of the date hereof. 
 1.6 Change of Control. The term “Change of Control” shall have the meaning set forth in the LLC Agreement. 
 1.7 Closing. The term “Closing” shall have the meaning set forth in Section 2.2. 
 1.8 Closing Date. The term “Closing Date” shall have the meaning set forth in Section 2.2. 
 1.9 Company. The term “Company” shall have the meaning set forth in the preface. 
 1.10 Constructive Termination. The term “Constructive Termination” shall have the meaning assigned such term in the Employment Agreement. 

1.11 Cost. The term “Cost” shall mean the price per Unit paid by Executive, if any, as proportionately adjusted for all
subsequent distributions of Units and other recapitalizations and less the amount of any distributions (excluding tax distributions) made with respect to the Units pursuant to the Company’s organizational documents; provided that
“Cost” may not be less than zero. 
 1.12 Disability. The term “Disability” shall have the meaning
assigned such term in the Employment Agreement. 
 1.13 Employee and Employment. The term “employee”
shall mean, without any inference as to negate Executive’s status as a member of the Company for all purposes hereunder (subject to the terms hereof) and for federal and other tax purposes, any employee (as defined in accordance with the
regulations and revenue rulings then applicable under Section 3401(c) of the Internal Revenue Code of 1986, as amended) of the Company or any of its Subsidiaries, and the term “employment” shall include service as a part- or
full-time employee or board member to the Company or any of its Subsidiaries. 
 1.14 Executive. The term
“Executive” shall have the meaning set forth in the preface. 

  
 2 

 1.15 Executive’s Group. The term “Executive’s Group” shall have
the meaning set forth in Section 4.1(a). 
 1.16 Fair Market Value. The term “Fair Market Value” used in
connection with the value of Units shall mean (a) if there is a public market for the equity of the Company or Apria on the applicable date, the value for the Units shall be implied by the average of the high and low closing bid prices of such
equity during the last 10 trading days on the stock exchange on which the equity is principally trading or (b) if there is no public market for the equity on such date, the value for the Units shall be determined in good faith by the Board
after consultation with the Chief Executive Officer and Chief Financial Officer of Apria, in either case assuming, for purposes of determining Fair Market Value, application of the distribution and dissolution provisions contained in Sections 4.4
and 5.2(b) of the LLC Agreement. 
 1.17 Financing Default. The term “Financing Default” shall mean an event
which would constitute (or with notice or lapse of time or both would constitute) an event of default under any of the financing documents of the Company or its Affiliates from time to time (collectively, the “Financing Agreements”)
and any restrictive financial covenants contained in the organizational documents of the Company or its Affiliates. 
 1.18
LLC Agreement. The term “LLC Agreement” shall have the meaning set forth in the Securityholders Agreement. 

1.19 Management Investors. The term “Management Investors” shall have the meaning set forth in the preface. 

1.20 Permitted Transferee. The term “Permitted Transferee” means any Person to whom Executive transfers Units in
accordance with the Securityholders Agreement (other than the Sponsor and the Company and their respective Affiliates and except for transfers pursuant to a Public Offering). 
 1.21 Person. The term “Person” shall mean any individual, corporation, partnership, limited liability company, trust, joint stock company, business trust, unincorporated association,
joint venture, governmental authority or other entity of any nature whatsoever. 
 1.22 Public Offering. The term
“Public Offering” shall have the meaning set forth in the Securityholders Agreement. 

  
 3 

 1.23 Restrictive Covenant Violation. The term “Restrictive Covenant
Violation” shall mean Executive’s material breach of any section in Appendix A hereto. 
 1.24 Securities Act.
The term “Securities Act” shall mean the Securities Act of 1933, as amended, and all rules and regulations promulgated thereunder, as the same may be amended from time to time. 

1.25 Securityholders Agreement. The term “Securityholders Agreement” shall mean the Amended and Restated Securityholders
Agreement dated as of April 8, 2010 among the Sponsor, one or more Management Investors and the Company, as it may be amended or supplemented thereafter from time to time. 

1.26 Sponsor. The term “Sponsor” means Blackstone. 

1.27 Subsidiary. The term “Subsidiary” means any corporation, limited liability company, partnership or other entity
with respect to which another specified entity has the power to vote or direct the voting of sufficient securities to elect directors (or comparable authorized persons of such entity) having a majority of the voting power of the board of directors
(or comparable governing body) of such entity. 
 1.28 Termination Date. The term “Termination Date” means the
date upon which Executive’s employment with the Company and its Subsidiaries is terminated. 
 1.29 Unvested Units.
The term “Unvested Units” means, with respect to Executive’s Class B Units, the number of such Units that are not “Vested Units”. 
 1.30 Vested Units. The term “Vested Units” shall mean all of Executive’s Class A-2 Units and the number of Class B Units that are vested and nonforfeitable. With respect to
Executive’s Class B Units, the number of such Units that are Vested Units is determined in accordance with Schedule I attached hereto. With respect to Executive’s Class A-2 Units, all such Units will be fully vested upon issuance.

  

	2.	Subscription for and Grant of Units. 

 2.1 Issuance of Units. Pursuant to the terms and subject to the conditions set forth in this Agreement, Executive hereby subscribes for and agrees to acquire, and the Company hereby agrees to issue

  
 4 

 
to Executive on the Closing Date (except as provided in this paragraph below), the number and classes of “Initial Class A-2 Units” and “Class B Units” set forth on
Executive’s Master Signature Page in exchange (a) in the case of the Class A-2 Units, for the cash purchase price set forth on Executive’s Master Signature Page and (b) in the case of the Class B Units, for services
performed for the Company and its Subsidiaries by Executive. Furthermore, for a period of six months following the Closing Date, Executive shall have the right, but not the obligation, to subscribe for and agree to acquire, and the Company hereby
agrees to issue to Executive upon written notice from Executive of his election to purchase, an additional number of Class A-2 Units, up to the number of “Additional Class A-2 Units” set forth on Executive’s Master Signature
Page, in exchange for the cash purchase price per Unit set forth on the Executive’s Master Signature Page. The Class A-2 Units and Class B Units shall be subject to the following terms: 

(a) Catchup for Class A-2 Units. Notwithstanding anything to the contrary in the LLC Agreement, Executive’s
distributions in respect of each Class A-2 Unit in excess of $1.00 per Class A-2 Unit shall be foregone and shall instead be distributed in respect of other Units until such time as the cumulative foregone distributions in respect of each
such Class A-2 Unit equals $0.10 (the “Delayed Amount Per Class A-2 Unit”). Once the Delayed Amount Per Class A-2 Unit has been foregone, Executive shall then be entitled to receive 100% of all subsequent distributions to
holders of Units until Executive shall have received distributions in respect of this sentence per Unit equal to the Delayed Amount Per Class A-2 Unit. Thereafter, Executive shall be entitled to receive distributions in connection with each
Class A-2 Unit calculated in the same manner as other Class A-2 Units. The intent of the foregoing exclusion is to ensure that the Executive’s Class A-2 Units do not participate in a distribution of any profits or increase in the
value of the Company created prior to the Closing Date to the extent exceeding Executive’s $1.00 per Class A-2 Unit capital contribution (except and until distributions in excess of such $1.00 exceed $0.10 per Class A-2 Unit
distributable to current Class A-2 Unitholders other than Executive), such that the interests in excess of the Executive’s capital contribution on the Class A-2 Units qualify as “profits interests” on the date of the
conversion under applicable tax laws. 
 (b) Catchup for Class B Units. Notwithstanding anything to the contrary in the
LLC Agreement, Executive’s initial distributions in respect of each Class B Unit (whether or not then vested) shall be foregone and shall instead be distributed in respect of other Units until such time as the cumulative foregone distributions
in respect of each such Class B Unit equals $0.10 (the “Delayed Amount Per Class B Unit”). Once the Delayed Amount Per Class B Unit has been foregone, Executive shall then be entitled to receive 100% of all subsequent distributions to
holders of Units until Executive shall have received distributions in respect of this sentence per Unit equal to the Delayed Amount Per Class B Unit. Thereafter, Executive shall be entitled to receive distributions in connection with each Class B
Unit calculated in the same manner as other Class B Units. The intent of the foregoing exclusion is to ensure that the Class B Units do not participate in a distribution of any profits or increase in the value of the Company created prior to the
Closing Date, such that the Class B Units qualify as “profits interests” on the date of the conversion under applicable tax laws. 

  
 5 

 (c) Preemptive Rights. 

(i) Notwithstanding anything to the contrary in the Securityholders Agreement, at any time that the Company (after the
Closing Date and prior to the first Public Offering or any Termination Date) proposes to issue or sell to any Person any common membership units (“Common Equity”) or other equity securities or any securities convertible into or
exchangeable for any such common membership units or other equity securities (other than: (i) in connection with any Public Offering (or any restructuring related to a Public Offering), (ii) pursuant to any present or future employee,
officer or director benefit plan or program of or assumed by the Company or any of its Subsidiaries, (iii) as consideration in any merger, consolidation, acquisition for stock, business combination or any similar extraordinary transaction or
(iv) the issuance of Common Equity or other equity securities as a dividend or distribution to all or substantially all holders of Common Equity or other equity securities, or a subdivision or combination of Common Equity or other equity
securities or a reclassification of (or similar action with respect to) Common Equity or other equity securities into a greater or lesser number of Common Equity or other equity securities available to all holders of the applicable class of Common
Equity), Executive at such time shall be afforded the opportunity to acquire from the Company for the same price (net of any underwriting discounts or sales commissions) and on the same terms as such Common Equity or other equity securities are
proposed to be offered (or, to the extent such Common Equity or other equity securities are offered for consideration (or the exercise price of which is to be paid in consideration) other than cash, the cash equivalent thereof) an amount of Common
Equity or other equity securities up to the aggregate amount of Common Equity or other equity securities to be offered or sold multiplied by Executive’s percentage ownership interest in the Class A Units. 

(ii) If the Company or any of its Subsidiaries proposes to offer or sell Common Equity or other equity securities that are
subject to this Section 2.1(c), the Company shall give Executive written notice (a “Subscription Notice”) of its intention, describing the type of such Common Equity or other equity securities, price (or range of prices), anticipated
amount of such Common Equity or other equity securities, timing, and other terms upon which the Company proposes to issue or sell the same. Executive shall have 10 days from the date of receipt of a Subscription Notice to notify the Company in
writing (a “Participation Notice”) that he intends to exercise his rights provided in this Section 2.1(c) and the amount of such Common Equity or other equity securities Executive desires to purchase, which amount may not exceed the
maximum amount calculated pursuant to Section 2.1(c). Such Participation Notice shall constitute a nonbinding indication of interest of Executive to purchase the amount of such Common Equity or other equity securities so specified at the price
and other terms set forth in the Company’s notice to Executive. The failure of Executive to respond within such 10-day period shall be deemed to be a waiver of Executive’s rights under this Section 2.1(c) only with respect to the
offering described in the applicable Subscription Notice. 
 (iii) If Executive exercises his rights provided in
this Section 2.1(c), the closing of the purchase of the Common Equity or other equity securities with respect to which such right has been exercised shall take place no less than 15 days and no later than 180 days after the giving of the
Participation Notice, which period of time shall be extended for a maximum of 60 days in order to comply with applicable laws and 

  
 6 

 
regulations (including receipt of any applicable regulatory approvals). The Company and Executive will use commercially reasonable efforts to secure on a timely basis any regulatory approvals or
other consents, and to comply with any law or regulation necessary in connection with the issuance, sale and purchase of, such Common Equity or other equity securities. 

(iv) Notwithstanding the foregoing provisions of this Section 2.1(c), the Board may cause the Company to proceed with
any issuance or sale of Common Equity or other equity securities prior to having complied with such foregoing provisions; provided that the Company will subsequently comply with the other provisions of this Section 2.1(c) subsequent to such
issuances on a prompt basis. 
 (d) Public Offering. 

(i) Without limiting the generality of Section 2.10 of the LLC Agreement, in connection with a Public Offering,
the Company will offer to Executive the opportunity to effect a Class B Exchange; provided that the equity securities in to which the Class B Units are exchanged will remain subject to the terms and conditions hereof (including, for the
avoidance of doubt, Section 4.2 and the vesting terms hereunder). 
 (ii) Notwithstanding anything to the
contrary in the Securityholders Agreement or the LLC Agreement: (A) upon the date that is 180 calendar days after the Company’s first Public Offering, all restrictions on Transfers (as defined in the Securityholders Agreement) of Units
shall expire with respect to all of Executive’s Vested Units, including any and all Units acquired by Executive subsequent to the Closing Date (provided that such Units shall be exchanged into common equity of the issuer in such Public Offering
prior to any such Transfer); and (B) immediately upon the Company’s first Public Offering, all rights of first refusal upon any Transfers (as defined in the Securityholders Agreement) of Units, shall expire with respect to all of
Executive’s Units, including any and all Units acquired by Executive subsequent to the Closing Date. 
 2.2 The
Closing. The closing (the “Closing”) of the grant of Units hereunder shall take place on December 5, 2012. The date of the Closing shall be the “Closing Date”. 

2.3 Section 83(b) Election. Within 10 days after the Closing, Executive shall provide the Company with a copy of a completed
election under Section 83(b) of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder in the form of Exhibit A to Executive’s Master Signature Page. Executive shall timely (within 30 days of the Closing)
file (via certified mail, return receipt requested) such election with the Internal Revenue Service and shall thereafter notify the Company it has made such timely filing. Executive should consult his tax advisor regarding the consequences of a
Section 83(b) election, as well as the receipt, vesting, holding and sale of Units. 

  
 7 

 2.4 Closing Conditions. Notwithstanding anything in this Agreement to the contrary,
the Company shall be under no obligation to issue, grant to Executive any Units unless (i) Executive is an employee of, or consultant to, the Company or one of its Subsidiaries on the Closing Date; (ii) the representations of Executive
contained in Section 3 hereof are true and correct in all material respects as of the Closing Date and (iii) Executive is not in breach of any agreement, obligation or covenant herein required to be performed or observed by Executive on or
prior to the Closing Date. 
  

	3.	Investment Representations and Covenants of Executive. 

 3.1 Units Unregistered. Executive acknowledges and represents that Executive has been advised by the Company that: 
 (a) the offer and sale of the Units have not been registered under the Securities Act; 
 (b) the Units must be held indefinitely and Executive must continue to bear the economic risk of the investment in the Units unless the offer and sale of such Units are subsequently registered under the
Securities Act and all applicable state securities laws or an exemption from such registration is available (or as otherwise provided in the Securityholders Agreement); 
 (c) there is no established market for the Units and it is not anticipated that there will be any public market for the Units in the foreseeable future; 

(d) a restrictive legend in the form set forth below and the legends set forth in Section 7.3(a) and (b) of the Securityholders
Agreement shall be placed on the certificates, if any, representing the Units: 
 “THE SECURITIES REPRESENTED BY THIS
CERTIFICATE ARE SUBJECT TO CERTAIN REPURCHASE OPTIONS AND OTHER PROVISIONS SET FORTH IN A MANAGEMENT UNITS SUBSCRIPTION AGREEMENT WITH THE ISSUER, AS AMENDED AND MODIFIED FROM TIME TO TIME, A COPY OF WHICH MAY BE OBTAINED BY THE HOLDER HEREOF AT THE
ISSUER’S PRINCIPAL PLACE OF BUSINESS WITHOUT CHARGE”; and 
 (e) a notation shall be made in the appropriate records
of the Company indicating that the Units are subject to restrictions on transfer and, if the Company should at some time in the future engage the services of a securities transfer agent, appropriate stop-transfer instructions will be issued to such
transfer agent with respect to the Units. 
 3.2 Additional Investment Representations. Executive represents and warrants
that: 
 (a) Executive’s financial situation is such that Executive can afford to bear the economic risk of holding the
Units for an indefinite period of time, has adequate means for providing for Executive’s current needs and personal contingencies, and can afford to suffer a complete loss of Executive’s investment in the Units; 

  
 8 

 (b) Executive’s knowledge and experience in financial and business matters are such
that Executive is capable of evaluating the merits and risks of the investment in the Units; 
 (c) Executive understands that
the Units are a speculative investment which involves a high degree of risk of loss of Executive’s investment therein, there are substantial restrictions on the transferability of the Units and, on the Closing Date and for an indefinite period
following the Closing, there will be no public market for the Units and, accordingly, it may not be possible for Executive to liquidate Executive’s investment in case of emergency, if at all; 

(d) the terms of this Agreement provide that if under certain circumstances Executive ceases to be an employee of the Company or its
Subsidiaries, the Company and its Affiliates have the right to repurchase the Units at a price which may, under certain circumstances, be less than the Fair Market Value thereof; 

(e) Executive understands and has taken cognizance of all the risk factors related to the purchase of the Units and, other than as set
forth in this Agreement, no representations or warranties have been made to Executive or Executive’s representatives concerning the Units or the Company or their prospects or other matters; 

(f) Executive has been given the opportunity to examine all documents and to ask questions of, and to receive answers from, the Company
and its representatives concerning the Company and its Subsidiaries, the Securityholders Agreement, the Company’s organizational documents and the terms and conditions of the purchase of the Units and to obtain any additional information which
Executive deems necessary; 
 (g) to the best of Executive actual knowledge, all information which Executive has provided to the
Company and the Company’s representatives concerning Executive and Executive’s financial position is complete and correct as of the date of this Agreement; and 
 (h) Executive is or is not an “accredited investor” within the meaning of Rule 501(a) under the Securities Act, as indicated on Executive’s Master Signature Page. 

3.3 Other Representations. Executive acknowledges that Blackstone and its Affiliates may, from time to time, provide services to
the Company and its Affiliates for which a fee will be paid by the Company or its Affiliates, including an annual monitoring/advisory fee. 

  
 9 

	4.	Certain Sales and Forfeitures Upon Termination of Employment; Variations to Securityholders Agreement. 

4.1 Put Option. 
 (a) Prior to the occurrence of the initial Public Offering, if Executive’s employment with the Company and its Subsidiaries terminates due to the death of Executive or is terminated by the Company or
any of its Subsidiaries as a result of the Disability of Executive, Executive and Executive’s Permitted Transferees (hereinafter sometimes collectively referred to as the “Executive’s Group”) shall have the right, subject
to the provisions of Section 5 hereof, for 180 days following the date that is 210 days after the Termination Date, to sell to the Company (the “Put Right”), and the Company shall be required to purchase (subject to the
provisions of Section 5 hereof), on one occasion from each member of Executive’s Group, all (but not less than all) of the number of Vested Units then held by Executive’s Group that equals all Vested Units collectively held by
Executive’s Group at a price per Unit equal to the Fair Market Value of such Units (measured as of the date that the relevant election to purchase such Units is delivered (the “Valuation Date”)). In order to exercise its rights
with respect to the Vested Units pursuant to this Section 4.1(a), Executive’s Group shall also be required to simultaneously exercise any similar rights it may have with respect to any other units of the Company held by Executive’s
Group in accordance with the terms of the agreements pursuant to which such other units were acquired from the Company. 
 (b)
If Executive’s Group desires to exercise the Put Right, the members of Executive’s Group shall send one written notice to the Company setting forth such members’ intention to collectively sell all of their Vested Units pursuant to
Section 4.1(a), which notice shall include the signature of each member of Executive’s Group. Subject to the provisions of Section 5.1, the closing of the purchase shall take place at the principal office of the Company on a date
specified by the Company no later than the 45th day after the giving of such notice. 
 4.2 Call Options. 

(a) If (1) Executive’s employment with the Company and its Subsidiaries is terminated for any reason (whether by the Company or
Executive, or as a result of death or Disability), (2) a Restrictive Covenant Violation occurs or (3) Executive engages in a Competitive Activity (as defined in Section 6 of this Agreement) not constituting a Restrictive Covenant
Violation without the consent of the Board, then the Company shall have the right, (x) for 210 days following the relevant event described in clause (1), (2) or (3) (or, in the case of clause (2) or (3) only, the date on
which the Board has actual knowledge (or reasonably should have knowledge) thereof) or (y) if applicable, to avoid adverse accounting treatment, for 210 days after the date that is six months and one day after the date on which Executive became
vested in the applicable Units, to purchase (the “Call Option”), and each member of Executive’s Group shall be required to sell to the Company, any or all Vested Units then held by such member of Executive’s Group (it
being understood that if Units of any class subject to repurchase hereunder may be repurchased at different prices, the Company may elect to repurchase only the portion of the Units of such class subject to repurchase hereunder at the lower price);
provided that the Class A-2 Units shall not be subject to a Call Option except in the circumstances described below in clause (i) or clause (iv). The purchase price per Unit under the Call Option shall be determined as follows: 

(i) Termination with Cause or Restrictive Covenant Violation; Voluntary Resignation when Grounds for Cause Exist.
If Executive’s employment with the Company and its Subsidiaries is terminated (x) by the Company or any of its Subsidiaries 

  
 10 

 
with Cause, (y) by Executive at a time when grounds exist for Cause, regardless of any notice, cure or waiting period thereunder, or (z) in the event of a Restrictive Covenant
Violation, the purchase price per Unit will be lesser of (1) the Fair Market Value thereof (measured as of the Valuation Date) and (2) Cost (provided that, in the case of the Class A 2 Units under clause (x) above, the purchase
price per Unit will be the Fair Market Value thereof (measured as of the Valuation Date)). 
 (ii) Death or
Disability; Termination without Cause; Resignation for Constructive Termination. If Executive’s employment with the Company and its Subsidiaries is terminated (w) by the Company or any of its Subsidiaries as a result of the Disability
of Executive, (x) due to the death of Executive, (y) by the Company without Cause or (z) by Executive as a result of a Constructive Termination, the purchase price per Unit will be the Fair Market Value thereof (measured as of the
Valuation Date); 
 (iii) Voluntary Resignation. If Executive’s employment with the Company and its
Subsidiaries is terminated by Executive (other than as a result of a Constructive Termination) at a time when grounds do not exist for Cause, the purchase price per Unit will be: 

(A) if such termination occurs on or before the second anniversary of the Closing Date, the lesser of (A) Fair Market
Value thereof (measured as of the Valuation Date) and (B) Cost; or 
 (B) if such termination occurs after
the second anniversary of the Closing Date, the Fair Market Value thereof; and 
 (iv) Competitive
Activity. In the event Executive engages in a Competitive Activity not constituting a Restrictive Covenant Violation without the consent of the Board, the purchase price per Unit will be the Fair Market Value thereof (measured as of the
Valuation Date). 
 The Call Option in respect of Vested Units shall expire upon the occurrence of a Public Offering. 

(b) If Executive’s employment with the Company and its Subsidiaries is terminated for any reason, all Unvested Units (excluding, for
the avoidance of doubt, the Class A-2 Units) will be forfeited (or, to the extent a forfeiture is not permissible under applicable law for any reason, the Unvested Units shall be subject to the Call Option in Section 4.2(a) with the purchase
price per Unvested Unit equal to the lesser of (A) Fair Market Value thereof (measured as of the Valuation Date) and (B) Cost). Such Call Option shall apply without regard to whether a Public Offering has occurred. 

(c) If the Company desires to exercise its Call Option pursuant to this Section 4.2, the Company shall send written notice to each
member of Executive’s Group of its intention to purchase Units, specifying the number of Units to be purchased (the “Call Notice”). Subject to the provisions of Section 5, the closing of the purchase shall take place at
the principal office of the Company on a date specified by the Company no later than the 30th day after the giving of the Call Notice. 
 (d) Notwithstanding the foregoing, if the Company elects not to exercise its Call Option pursuant to this Section 4.2, the Sponsor may elect to purchase such Units at any time on the same terms and
conditions set forth in this Section 4.2 by providing written notice to each member of Executive’s Group of its intention to purchase Units. 

  
 11 

 4.3 Obligation to Sell Several. If there is more than one member of Executive’s
Group, the failure of any one member thereof to perform its obligations hereunder shall not excuse or affect the obligations of any other member thereof, and the closing of the purchases from such other members by the Company shall not excuse, or
constitute a waiver of its rights against, the defaulting member. 
  

	5.	Certain Limitations on the Company’s Obligations to Purchase Units. 

 5.1 Prohibition of Purchases. Notwithstanding anything to the contrary contained herein, the Company shall not be obligated to purchase any Units at any time pursuant to Section 4, regardless
of whether it has delivered a notice of its election to purchase any such Units, to the extent that the purchase of such Units or the payment to the Company or one of its Subsidiaries of a cash dividend or distribution by a Subsidiary of the Company
that is necessary to fund such purchase (together with any other purchases of Units pursuant to Section 4 or pursuant to similar provisions in agreements with other employees of the Company and its Subsidiaries of which the Company has at such
time been given or has given notice and together with cash dividends and distributions necessary to fund such other purchases) would result in a violation of any law, statute, rule, regulation, policy, order, writ, injunction, decree or judgment
promulgated or entered by any federal, state, local or foreign court or governmental authority applicable to the Company or any of its Subsidiaries or any of its or their property. The Company shall, within fifteen days of learning of any such fact,
so notify the members of Executive’s Group that it is not obligated to purchase Units hereunder. 
 5.2 Payment for
Units. If at any time the Company elects or is required to purchase any Units pursuant to Section 4, the Company shall pay the purchase price for the Units it purchases (i) first, by the cancellation of any indebtedness, if any, owing
from Executive to the Company or any of its Subsidiaries (which indebtedness shall be applied pro rata against the proceeds receivable by each member of Executive’s Group receiving consideration in such repurchase) and (ii) then, by the
Company’s delivery of a check or wire transfer of immediately available funds for the remainder of the purchase price, if any, against delivery of the certificates or other instruments, if any, representing the Units so purchased, duly
endorsed; provided that if (x) any of the conditions set forth in Section 5.1 exists or (y) such purchase of Units would result in a Financing Default, in each case which prohibits such cash payment (either directly or
indirectly as a result of the prohibition of a related cash dividend or distribution) (each a “Cash Payment Restriction”), the portion of the cash payment so prohibited may be made, to the extent such payment is not prohibited, by
the Company’s delivery of a junior subordinated promissory note (which shall be subordinated and subject in right of payment to the prior payment of any debt 

  
 12 

 
outstanding under the senior Financing Agreements and any modifications, renewals, extensions, replacements and refunding of all such indebtedness of the Company (a “Junior Subordinated
Note”) in a principal amount equal to the balance of the purchase price, payable within ten days after the Cash Payment Restriction no longer exists, and bearing interest payable (and compounded to the extent not so paid) as of the last day
of each year at the interest rate payable under the senior financing credit facilities of the Company or its Subsidiaries (as applicable) from time to time, and all such accrued and unpaid interest payable on the date of the payment of principal
(or, if applicable, the last installment of principal), with payments to be applied in the order of: (A) first to any enforcement costs incurred by Executive or Executive’s Group, (B) second to interest and (C) third to
principal. The Company shall have the right set forth in clause (i) of the first sentence of this Section 5.2 whether or not the member of Executive’s Group selling such Units is an obligor of the Company. The principal of, and
accrued interest on, any such Junior Subordinated Note may be prepaid in whole or in part at any time at the option of the Company. To the extent that the Company is prohibited from paying accrued interest, that is required to be paid on any Junior
Subordinated Note prior to maturity, due to the existence of any Cash Payment Restriction, such interest shall be cumulated, compounded calendar quarterly, and accrued until and to the extent that such Cash Payment Restriction no longer exists, at
which time such accrued interest shall be immediately paid. Notwithstanding any other provision in this Agreement, the Company may elect to pay the purchase price hereunder in shares or other equity securities of one of its direct or indirect
Subsidiaries with a fair market value equal to the applicable purchase price, provided that such Subsidiary promptly offers to repurchase such shares or other equity securities for cash equal to the applicable purchase price or a Junior
Subordinated Note (if otherwise permissible hereunder) with a principal amount equal to the applicable purchase price. 
 5.3
Repayment of Proceeds. In the event the Company terminates Executive for Cause or Executive resigns at a time when grounds for Cause exist (and the Company discovers no later than 30 calendar days after such resignation that grounds existed
for Cause at the time thereof and notifies Executive of such fact during 30-day period), then Executive shall be required to pay to the Company, within 10 business days’ of the Company’s request to Executive therefor, an amount equal to
the excess, if any, of (A) the aggregate after-tax proceeds (taking into account all amounts of tax that would be recoverable upon a claim of loss for payment of such proceeds in the year of repayment) Executive received upon the sale or other
disposition of, or distributions in respect of, Executive’s Class B Units over (B) the aggregate Cost of such Units. The foregoing shall not apply in respect to any event that occurs after a Public Offering if Executive was employed
by the Company at the time of the Public Offering. 
  

	6.	Restrictive Covenant Violation; Competitive Activity. 

 (a) Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and its Affiliates and accordingly agrees, in his capacity as an investor and equityholder in the
Company and its Affiliates, to the provisions of Appendix A to this Agreement. Executive acknowledges and agrees that the Company’s remedies at law for a 

  
 13 

 
breach of any of the provisions of Appendix A would be inadequate and the Company would suffer irreparable damages as a result of such breach. In recognition of this fact, Executive agrees that,
in the event of such a breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to cease making any payments or providing any benefit otherwise required by this Agreement and obtain equitable relief in the
form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available. 
 (b) Executive shall be deemed to have engaged in “Competitive Activity” if, after the Restricted Period (as defined in Appendix A), Executive accepts an employment or consulting relationship (or
acquires any financial interest in), directly or indirectly, with a Direct Competitor of the Company. For the purposes of the foregoing, a “Direct Competitor” means any entity that is in direct competition with the business of the Company
and which derives at least 20% of its revenue from engaging in the business of home respiratory therapy, home infusion therapy, and home medical equipment that is competitive with the Company and its Subsidiaries within the United States. For the
avoidance of doubt, any conduct that constitutes Competitive Activity but not a Restrictive Covenant Violation shall not be prohibited hereby, but instead shall serve to provide that the Call Option may be exercised pursuant to Section 4.2
hereof. 
  

	7.	Miscellaneous. 

 7.1
Transfers. Prior to the transfer of Units to a Permitted Transferee, Executive shall deliver to the Company a written agreement of the proposed transferee (a) evidencing such Person’s undertaking to be bound by the terms of this
Agreement and (b) acknowledging that the Units transferred to such Person will continue to be Units for purposes of this Agreement in the hands of such Person. Any transfer or attempted transfer of Units in violation of any provision of this
Agreement or the Securityholders Agreement shall be void, and the Company shall not record such transfer on its books or treat any purported transferee of such Units as the owner of such Units for any purpose. 

7.2 Recapitalizations, Exchanges, Etc., Affecting Units. The provisions of this Agreement shall apply, to the full extent set
forth herein with respect to Units, to any and all securities of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of, in exchange for, or in
substitution of the Units, by reason of any dividend payable in units, issuance of units, combination, recapitalization, reclassification, merger, consolidation or otherwise. 
 7.3 Executive’s Employment by the Company. Nothing contained in this Agreement shall be deemed to obligate the Company or any Subsidiary of the Company to employ Executive in any capacity
whatsoever or to prohibit or restrict the Company (or any such Subsidiary) from terminating the employment of Executive at any time or for any reason whatsoever, with or without Cause. 

  
 14 

 7.4 Cooperation. Executive agrees to cooperate with the Company in taking action
reasonably necessary to consummate the transactions contemplated by this Agreement. 
 7.5 Binding Effect. The provisions
of this Agreement shall be binding upon and accrue to the benefit of the parties hereto and their respective heirs, legal representatives, successors and assigns; provided, however, that no Permitted Transferee shall derive any rights under this
Agreement unless and until such Permitted Transferee has executed and delivered to the Company a valid undertaking and becomes bound by the terms of this Agreement; and provided further that the Sponsor is a third party beneficiary of this Agreement
and shall have the right to enforce the provisions hereof. 
 7.6 Amendment; Waiver. This Agreement may be amended only
by a written instrument signed by the parties hereto. No waiver by any party hereto of any of the provisions hereof shall be effective unless set forth in a writing executed by the party so waiving. 

7.7 Governing Law; Jurisdiction. This Agreement shall be governed by and construed and enforced in accordance with the laws of the
State of Delaware applicable to contracts made and to be performed therein. Any suit, action or proceeding with respect to this Agreement, or any judgment entered by any court in respect of any thereof, shall be brought in any court of competent
jurisdiction in the State of New York or the State of Delaware, and each of the Company and the members of Executive’s Group hereby submits to the exclusive jurisdiction of such courts for the purpose of any such suit, action, proceeding or
judgment. Each of the members of Executive’s Group and the Company hereby irrevocably waives (i) any objections which it may now or hereafter have to the laying of the venue of any suit, action or proceeding arising out of or relating to
this Agreement brought in any court of competent jurisdiction in the State of Delaware or the State of New York, (ii) any claim that any such suit, action or proceeding brought in any such court has been brought in any inconvenient forum and
(iii) any right to a jury trial. 
 7.8 Notices. All notices and other communications hereunder shall be in writing
and shall be deemed to have been duly given when delivered by hand or overnight courier or three postal delivery days after it has been mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the respective
addresses set forth below in this Agreement, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 

(a) If to the Company: 
 Apria Holdings LLC 
 c/o Apria Healthcare Group Inc. 

Apria Healthcare Group Inc. 
 26220 Enterprise Court 
 Lake Forest, California 92630 

Attention: General Counsel 

  
 15 

 with a copy (which shall not constitute notice) to: 

The Blackstone Group 
 345 Park Avenue 
 New York, NY 10154 

Attention: Neil P. Simpkins 
 and 
 Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 
 New York, NY 10017-3954 
 Attention: Gregory T. Grogan 

If to Executive: 

To the most recent address of Executive set forth in the personnel records of the Company. 

with a copy (which shall not constitute notice) to: 
 Finck & Dadras LLP 
 100 Spear Street, Suite 700 

San Francisco, CA 94105 
 Attention: Kevin W. Finck 
 7.9 Integration. This Agreement and the
documents referred to herein (including referred to on the Executive Master Signature Page) or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to the subject matter hereof and thereof.
There are no restrictions, agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein and therein. This Agreement supersedes all prior agreements
and understandings between the parties with respect to such subject matter. 
 7.10 Counterparts. This Agreement may be
executed in separate counterparts, and by different parties on separate counterparts each of which shall be deemed an original, but all of which shall constitute one and the same instrument. 

  
 16 

 7.11 Injunctive Relief. The Company, Executive and Executive’s Permitted
Transferees each acknowledges and agrees that a violation of any of the terms of this Agreement will cause the Company, Executive or Executive’s Permitted Transferees, as the case may be, irreparable injury for which adequate remedy at law is
not available. Accordingly, it is agreed that the Company, Executive or Executive’s Permitted Transferees may seek an injunction, restraining order or other equitable relief to prevent breaches of the provisions of this Agreement and to enforce
specifically the terms and provisions hereof in any court of competent jurisdiction in the United States or any state thereof, in addition to any other remedy to which it may be entitled at law or equity. 

7.12 Rights Cumulative; Waiver. The rights and remedies of Executive and the Company under this Agreement shall be cumulative and
not exclusive of any rights or remedies which either would otherwise have hereunder or at law or in equity or by statute, and no failure or delay by either party in exercising any right or remedy shall impair any such right or remedy or operate as a
waiver of such right or remedy, nor shall any single or partial exercise of any power or right preclude such party’s other or further exercise or the exercise of any other power or right. The waiver by any party hereto of a breach of any
provision of this Agreement shall not operate or be construed as a waiver of any preceding or succeeding breach and no failure by either party to exercise any right or privilege hereunder shall be deemed a waiver of such party’s rights or
privileges hereunder or shall be deemed a waiver of such party’s rights to exercise the same at any subsequent time or times hereunder. 
 7.13 Inconsistent Terms Superseded. The Company and Executive further agree that all terms and conditions of this Agreement shall control over and supersede any and all inconsistent terms and/or
conditions of the Securityholders Agreement, the LLC Agreement, and/or any other agreement to which the Company and/or Executive is/are a party that relates to the subject matter hereof. 

*    *    *    *    * 

  
 17 

*    *    *    *    * 

This Subscription Agreement between the Company and the Executive named on the Executive Master Signature Page hereto is dated and executed as of the
date set forth on such Executive Master Signature Page. 

*    *    *    *    * 

 SCHEDULE I 
 Vesting 
 All Class B Units initially will be Unvested Units. Subject to
Executive’s continued employment on each vesting date, Class B Units will become Vested Units as follows: 
  

	 	•	 	 20% of the Class B Units will become Vested Units the first anniversary of the Closing Date; and 

 

	 	•	 	 an incremental 5% of the Class B Units will become Vested Units on each succeeding three-month period thereafter for four years;

 Notwithstanding the foregoing, immediately prior to, and following, the occurrence (prior to the Termination Date) of a
Change of Control in which Blackstone ceases to control (directly, or indirectly through one or more intermediaries or contractual counterparties) the entity that employs Executive, all of the Class B Units that are Unvested Units shall become
Vested Units. 
 Any Unvested Units on a Termination Date shall be immediately forfeited by Executive (or, to the extent a forfeiture is not
permissible, such Unvested Units shall be subject to the Call Option in Section 4.2(a) with the purchase price per Unvested Unit equal to the lesser of (A) Fair Market Value thereof (measured as of the Valuation Date) and (B) Cost).

 Appendix A 

Restrictive Covenants 
  

	1.	Non-Competition. 

 (a)
Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and its affiliates and accordingly agrees as follows: 
 (i) Executive will not, within twenty-four months following the termination of Executive’s employment with Company or its subsidiaries (the “Post-Termination Period”) or during the period
of Executive’s employment with the Company or its subsidiaries (collectively with the Post-Termination Period, the “Restricted Period”), accept an employment or consulting relationship (or own or have any financial interest in),
directly or indirectly, with any entity which derives at least 10% of its revenue from engaging in the business of home respiratory therapy, home infusion therapy, and home medical equipment that is competitive with the Company and its Subsidiaries
within the United States (a “Competitive Business”). 
 (ii) During the Restricted Period, Executive
will not initiate or respond to communications with any of the employees of the Company or its subsidiaries who earned annually $50,000 or more as a Company or subsidiary employee during the twelve-month period prior to the termination of such
employee’s employment with the Company or subsidiary, for the purpose of soliciting such employee, or facilitating the hiring of any such employee, to work for any other business, individual, partnership, firm, corporation, or other entity.

 (iii) During the Restricted Period, Executive will not influence or attempt to influence customers of the
Company or its subsidiaries or any of its present or future subsidiaries or affiliates, either directly or indirectly, to divert their business to any individual, partnership, firm, corporation or other entity then in competition with the business
of the Company or any subsidiary or affiliate of the Company. 
 (iv) During the Restricted Period, Executive
will not, other than as required by law or by order of a court or other competent authority, make or publish, or cause any other person to make or publish, any statement that is disparaging or that reflects negatively upon the Company or its
affiliates, or that is or reasonably would be expected to be damaging to the reputation of the Company or any subsidiary or affiliate of the Company. 
 Notwithstanding anything to the contrary in this Agreement, Executive may, directly or indirectly own, solely as an investment, securities of any person engaged in a Competitive Business which are
publicly traded on a national or regional stock exchange or on the over-the-counter market if Executive (i) is not a controlling person of, or a member of a group which controls, such person and (ii) does not, directly or indirectly, own
5% or more of any class of securities of such person. 

  
 A-2

 (b) It is expressly understood and agreed that although Executive and the Company consider
the restrictions contained in this Appendix A to be reasonable, if a final judicial determination is made by a court of competent jurisdiction, that the time or territory or any other restriction contained in this Appendix A is an unenforceable
restriction against Executive, the provisions of this Appendix A shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to
be enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the
enforceability of any of the other restrictions contained herein. 
 (c) The period of time during which the provisions of this
Appendix A shall be in effect shall be extended by the length of time during which Executive is in breach of the terms hereof as determined by any court of competent jurisdiction on the Company’s application for injunctive relief. 

 

	2.	Confidentiality. 

 (a)
Executive will not at any time (whether during or after Executive’s employment with the Company) (x) retain or use for the benefit, purposes or account of Executive or any other person; or (y) disclose, divulge, reveal, communicate,
share, transfer or provide access to any person outside the Company (other than its professional advisers who are bound by confidentiality obligations), any non-public, proprietary or confidential information — including without limitation
trade secrets, know-how, research and development, software, databases, inventions, processes, formulae, technology, designs and other intellectual property, information concerning finances, investments, profits, pricing, costs, products, services,
vendors, customers, clients, partners, investors, personnel, compensation, recruiting, training, advertising, sales, marketing, promotions, government and regulatory activities and approvals — concerning the past, current or future business,
activities and operations of the Company, its subsidiaries or affiliates and/or any third party that has disclosed or provided any of same to the Company on a confidential basis (“Confidential Information”) without the prior written
authorization of the Board. 
 (b) “Confidential Information” shall not include any information that is (a) a
matter of public knowledge; (b) is independently developed by a person not a party to this Agreement without the use, directly or indirectly, of Company information; (c) was in Executive’s possession prior to providing services for
the Company, provided that said information was not obtained from the Company; (d) is information of a general nature that could reasonably be acquired by Executive if employed by a similar business as Company; (e) is obtained by Executive
from a third party not subject to any confidentiality obligation to the Company; or (f) is required to be disclosed by law or the order of any court or governmental 

  
 A-3

 
agency, or in any litigation or similar proceeding; provided that prior to making any such required disclosure, Executive shall notify the Company in sufficient time to permit the Company to seek
an appropriate protective order. 
 (c) Except as required by law, Executive will not disclose to anyone, other than
Executive’s immediate family and legal or financial advisors, the existence or contents of this Agreement; provided, that Executive may disclose to any prospective future employer the notice provisions of this Appendix A provided they
agree to maintain the confidentiality of such terms. 
 (d) Upon termination of Executive’s employment with the Company for
any reason, Executive shall (x) cease and not thereafter commence use of any Confidential Information or intellectual property (including without limitation, any patent, invention, copyright, trade secret, trademark, trade name, logo, domain
name or other source indicator) owned or used by the Company, its subsidiaries or affiliates; (y) immediately destroy, delete, or return to the Company, at the Company’s option, all originals and copies in any form or medium (including
memoranda, books, papers, plans, computer files, letters and other data) in Executive’s possession or control (including any of the foregoing stored or located in Executive’s office, home, laptop or other computer, whether or not Company
property) that contain Confidential Information or otherwise relate to the business of the Company, its affiliates and subsidiaries, except that Executive may retain only those portions of any personal notes, notebooks and diaries that do not
contain any Confidential Information and Executive’s rolodex (or other physical or electronic address book); and (z) fully cooperate with the Company regarding the delivery or destruction of any other Confidential Information not within
Executive’s possession or control of which Executive is or becomes aware. Notwithstanding the foregoing, Executive may retain Executive’s rolodex and similar address books. To the extent that Executive is provided with a cell phone number
by the Company during employment, the Company shall cooperate with Executive in transferring such cell phone number to Executive’s individual name following termination. 
 (e) The provisions of Appendix A shall survive the termination of Executive’s employment for any reason. 

  
 A-4EX-10.31

 Exhibit 10.31 
 EXECUTIVE EMPLOYMENT AGREEMENT 
 This Executive Employment Agreement (this
“Agreement”) is entered into by and between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and Daniel J. Starck (the “Executive”) as of March 14, 2012 (the “Effective
Date”). 
 RECITALS 
 A. It is the desire of the Company to retain the services of the Executive and to recognize the Executive’s contribution to the Company during the course of his employment. 

B. The Company and the Executive wish to set forth certain terms and conditions of the Executive’s employment. 

C. The Company wishes to provide to the Executive certain benefits in the event that his employment is terminated by the Company
without Cause (as defined below) or in the event that he terminates employment for Good Reason (as defined below), in order to encourage the Executive’s performance and continued commitment to the Company. 

NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the parties hereto
agree as follows: 
 1. Term; Positions and Duties. 

(a) Term. The Company hereby agrees to employ the Executive and the Executive hereby agrees to accept such employment, upon
the terms and conditions hereinafter set forth. The Executive’s employment shall continue until its termination by reason of the Executive’s written resignation, termination by the Company for any reason by written notice of termination,
or death (the “Period of Employment”). The Executive’s employment may be terminated at any time by written notice from the Executive to the Company or from the Company to the Executive, in the manner provided in Section 6 hereof.

 (b) Position and Duties. The Executive shall serve as the Chief Executive Officer of the Company’s
subsidiary, Apria Healthcare, Inc. (“Apria Healthcare”), with direct reporting responsibility to the Chief Executive Officer of the Company. Subject to the terms and conditions set forth further herein, the Executive shall have full
responsibility for Apria Healthcare’s respiratory therapy/home medical equipment business and shall undertake such other duties and have such authority for the Company and Apria Healthcare as the Company, through its Chief Executive Officer and
board of directors (the “Board”), shall assign to the Executive from time to time in the Company’s sole and absolute discretion; provided such duties and responsibilities are the types of duties and responsibilities that would
ordinarily be assigned to a person with employment experience and position comparable to that of the Executive and are consistent with the policies, procedures and guidelines of the Company, applicable laws and this Agreement. The Executive agrees
to devote substantially all of his working time and efforts to the business and affairs of the Company. The Executive further agrees that he shall not undertake any outside activities which create a conflict of interest with his duties to the
Company and Apria Healthcare, or which, in the judgment of the Chief Executive Officer or Board, interfere with the performance of the Executive’s duties to the Company and Apria Healthcare. 

  
 1 

 2. Compensation and Benefits. 

(a) Salary. Beginning with the Effective Date, the Company shall pay to the Executive a base salary at the rate of $580,000
per year, in accordance with its regular practices and policies. The Company may increase the Executive’s salary from time to time. 
 (b) Bonuses. During the Period of Employment, the Executive shall be eligible to participate in the Company’s Executive Bonus Plan, or such other bonus plans applicable to the
Executive’s position as in effect from time to time. Promptly following the Effective Date, the Company shall pay the Executive a signing bonus in the amount of $170,000 (the “Signing Bonus”). Executive shall repay to the Company a
pro rata percentage of such Signing Bonus if the Executive voluntarily terminates his employment hereunder on or prior to the first anniversary of the Effective Date, with such percentage equal to the excess, if any, of (i) 100 over (ii) a
fraction, the numerator of which is the number of days that have elapsed between the Effective Date and the termination date and the denominator of which is 365. Each fiscal year, the Executive’s target bonus under the applicable year’s
Executive Bonus Plan will be an amount equal to 100% of his base salary paid in such year, and his maximum bonus potential will be equal to 200% of such base salary if maximum achievement levels are reached; provided however that with respect to
fiscal year 2012, the bonus payable to Executive under the Executive Bonus Plan, or such other bonus plans applicable to the Executive’s position, shall be at least $350,000. 

(c) Equity Awards. Contemporaneously with this Agreement, the Company shall grant Executive Class B Units in Apria Holdings
LLC (“Holdings”) pursuant to the terms contained in the subscription agreement attached hereto as Exhibit B. 

(d) Other Employee Benefits. During the Period of Employment, the Executive shall be entitled to participate in the
Company’s group life, health and disability insurance plans, the Company’s 401(k) Savings Plan as well as the Senior Executive Medical and Dental Programs, subject in all respects to the terms and conditions of those plans and programs. In
addition, the Executive shall be entitled to participate in all other employee benefit plans, programs and arrangements of the Company (including, without limitation, annual bonus, equity compensation, welfare, fringe, retirement, savings, vacation,
deferred compensation and any other plans, programs and arrangements) applicable to senior executives or employees of the Company generally, in accordance with the terms of such plans, programs or arrangements as they shall be in effect from time to
time during the term of the Executive’s employment; provided, however, that nothing herein shall entitle the Executive to any specific awards under the Company’s equity compensation plans or other discretionary employee benefit plans.
Subject to the terms and conditions set forth further herein, the parties to this Agreement recognize that the Company may terminate or modify such plans, programs or arrangements at any time without the consent of the Executive. 

(f) Vacation and Fringe Benefits. The Executive shall be entitled to take vacation days each year in accordance with the
Company’s “honor system” vacation policy or any other vacation policy and practice that becomes applicable to other senior executives of the Company from time to time. Notwithstanding the foregoing, the Company acknowledges that the
Executive will be on paid vacation from May 14 through May 22, 2012. 

  
 2 

 (g) Expenses. During the Period of Employment, the Executive shall be entitled
to receive reimbursement for all reasonable and customary expenses incurred by the Executive in performing services for the Company in accordance with the Company’s reimbursement policies, as they may be in effect from time to time. The parties
to this Agreement recognize that such policies may be amended and/or terminated by the Company at any time without the consent of the Executive. The Company will also reimburse the Executive for all reasonable expenses incurred in connection with
the process resulting in the execution of this Agreement. In all events, any reimbursement made to the Executive pursuant to this Section 2(g) shall be made not later than the end of the calendar year following the year in which the related
expense was incurred, and the amount of expenses eligible for reimbursement during any calendar year will not affect the amount of expenses eligible for reimbursement during any subsequent calendar year. 

3. Grounds for Termination. Subject to the terms and conditions set forth further herein, the Executive’s employment may
be terminated by the Company or the Executive at any time, for any reason or no reason, with or without Cause or Good Reason (as such terms are defined below). The Executive’s employment may end for any one of the following reasons: 

(a) Without Cause or Without Good Reason. The Executive or the Company may terminate the Executive’s employment at any
time, without Cause (in the case of the Company) or without Good Reason (in the case of the Executive), by giving the other party to this Agreement notice of such termination, with Executive’s notice to be no less than forty-five (45) days
in advance of such termination. 
 (b) Death. The Executive’s employment hereunder shall terminate upon his
death. 
 (c) Disability. If the Company determines in good faith that the Executive has incurred a Disability (as
defined below), it may give the Executive written notice in accordance with Section 6 of this Agreement of its intention to terminate the Executive’s employment. In such event, the Executive’s employment shall terminate effective on
the 30th day following receipt of such notice by the Executive; provided that, within the 30-day following receipt, the Executive shall not have returned to full-time performance of his duties. For purposes of this Agreement, “Disability”
shall mean the Executive’s incapacity due to physical or mental impairment which substantially limits a major life activity and which renders the Executive unable to perform the essential functions of his position on a full-time basis for the
entire period of six (6) consecutive months, even with reasonable accommodation that does not impose an undue hardship on the Company. 
 (d) Cause. The Company may terminate the Executive’s employment for Cause. For purposes of this Agreement (except as set forth below), “Cause” shall mean that the Board, acting
in good faith based upon the information then known to the Company, determines that the Executive has (i) engaged in or committed willful misconduct; (ii) engaged in or committed theft, fraud or other conduct constituting a felony (other
than traffic related offenses or as a result of vicarious liability); (iii) refused or demonstrated an unwillingness to substantially perform his duties for a 30-day period after written demand for substantial performance that refers to this

  
 3 

 
Section 3(d) and is delivered by the Company that specifically identifies the manner in which the Company believes the Executive has not substantially performed his duties for the Company or
Apria Healthcare; (iv) refused or demonstrated an unwillingness to reasonably cooperate in good faith with any Company, Apria Healthcare or government investigation or provide testimony therein (other than such failure resulting from the
Executive’s disability); (v) engaged in or committed any willful act that is likely to and which does in fact have the effect of injuring the reputation or business of the Company or Apria Healthcare; (vi) willfully violated his
fiduciary duty or his duty of loyalty to the Company or Apria Healthcare or the Company’s Code of Ethical Business Conduct in any material respect; (vii) used alcohol or drugs (other than drugs prescribed to the Executive by a physician
and used by the Executive for their intended purpose for which they had been prescribed) in a manner which materially and repeatedly interferes with the performance of his duties hereunder or which has the effect of materially injuring the
reputation or business of the Company or Apria Healthcare; or (viii) engaged in or committed any other material breach of this Agreement or the Letter Agreement for a 30-day period after written notification is delivered by the Company that
specifically refers to this Section 3(d) and identifies the manner in which the Company believes the Executive has materially breached this Agreement. For purposes of the above clauses (i), (v) and (vi) of this Section 3(d), no
act, or failure to act, on the Executive’s part shall be considered willful unless done or omitted to be done, by him not in good faith or without reasonable belief that his action or omission was in the best interest of the Company.

 (e) Resignation for Good Reason. The Executive may resign on account of Good Reason (as defined below).

 4. Payments upon Termination. 
 (a) Without Cause or With Good Reason. In the event that the Executive’s employment is terminated by the Company for any reason other than death, Disability or Cause as defined in
Sections 3(b), (c) and (d) of this Agreement, or in the event that the Executive terminates his employment hereunder with Good Reason as defined in Section 4(c) of this Agreement, the Executive shall be entitled to receive
severance pay in an aggregate amount equal to 200% of his Annual Compensation, which shall be paid, subject to Section 11(b), in periodic installments in accordance with the Company’s customary payroll practices over a period of
twenty-four (24) months, less any amounts required to be withheld by applicable law, with the first such installment payable within ten (10) business days following the date the release referred to below in this Section 4(a) becomes
irrevocable under applicable law and in all events not later than the end of the month following the month in which the Executive’s Separation from Service (as such term is defined in Section 4(g)) occurs; provided, however, that any such
payment shall be contingent upon the Executive’s execution and delivery to the Company within 21 days of the termination of his employment (or such longer period as may be required under applicable law) of a valid release of all claims the
Executive may have against the Company in the form attached hereto as Exhibit A (which may be modified only to the extent necessary to reflect developments in applicable law that would jeopardize enforceability of such release unless the
modifications are not made), and not revoking such release within any revocation period provided under applicable law, and continued compliance with the restrictive covenants described in Sections 7, 8 and 9 below; and provided, further, that,
if the Executive provides such release of claims, in no event shall the Executive be entitled to payment pursuant to this Section 4(a) of less than $5,000, which amount the parties agree is good and adequate consideration, in and of itself, for
such release. The Company will also pay to the Executive any Accrued Obligations (as defined in Section 4(f) below). 

  
 4 

 (b) Annual Compensation. For purposes of this Section 4, the term
“Annual Compensation” means an amount equal to the Executive’s annual base salary at the rate in effect on the date on which the Executive received or gave written notice of his termination, plus the sum of (i) an amount equal to
the average of the annual bonuses with respect to the Company’s two (2) most recently completed fiscal years, if any, determined to be payable and/or paid to the Executive under the Company’s Executive Bonus Plan (or comparable bonus
plan) prior to such notice of termination (provided that if Executive has not been employed for two full annual bonus cycles, his annual bonus amount, for purposes of determining his Annual Compensation, for any year in which he did not participate
in the full annual bonus cycle shall be 100% of his then current base salary) and (ii) an amount determined by the Company from time to time in its sole discretion to be equal to the annual cost for the Executive of obtaining medical, dental
and vision insurance under COBRA, including the cost of his participation in the senior executive medical and dental programs. 

(c) Good Reason. For purposes of this Agreement, the term “Good Reason” means the occurrence of any of the
following, without the written consent of the Executive, unless such event is rescinded within ten (10) business days after the Executive notifies the Company in writing that he objects thereto: 

 

	 	(i)	any reduction in the Executive’s combined annual base salary and target level bonus percentage, except for a general one-time “across-the-board” salary
reduction not exceeding ten percent (10%) which is imposed simultaneously on all executive officers of the Company; 

  

	 	(ii)	the Company requires the Executive to be based at an office location which will result in an increase of more than thirty (30) miles in the Executive’s
one-way commute, or 

  

	 	(iii)	the Company does not permit the Executive to continue to serve as the Chief Executive Officer of Apria Healthcare, or of substantially the same business after a
corporate reorganization, or another mutually acceptable senior executive position; 

 provided,
however, that “Good Reason” shall cease to exist for an event on the 60th day following the earlier of the Company’s written notice of the change to the Executive or the Executive’s becoming aware thereof, unless the Executive has given the Company written notice of
his objection thereto prior to such date. 
 (d) Release of all Claims. The Executive understands and agrees that
the Company’s obligation to pay the Executive severance pay under this Agreement is subject to the Executive’s execution of a valid written waiver and release of all claims which the Executive may have against the Company and/or its
successors in the form attached hereto as Exhibit A. 
 (e) No Mitigation or Offset. Notwithstanding anything
herein to the contrary, the amount of any payment or benefit provided for in this Section 4 shall not be reduced, offset or 

  
 5 

 
subject to recovery by the Company or any of its subsidiaries or affiliates by reason of any compensation earned by the Executive as the result of employment by another employer after the
Executive’s employment with the Company terminates for any reason. In addition, the Executive shall be under no obligation to seek other employment or to take any other actions to mitigate the amounts payable under this Section 4.

 (f) Death, Disability, Cause or Without Good Reason. In the event that the Executive’s employment is
terminated due to death, disability, Cause or by the Executive without Good Reason, the Company shall not be obligated to pay the Executive any amount other than accrued and unpaid vacation, reimbursement for business expenses incurred prior to his
termination and in compliance with the Company’s reimbursement policies, any unpaid salary for days worked prior to the termination, all other amounts accrued and earned by the Executive through the date of termination under the then existing
plans and policies of the Company, and any amounts owing in respect of the Company’s indemnification obligations to the Executive (collectively, the “Accrued Obligations”). 

(g) Separation from Service. As used herein, a “Separation from Service” occurs when the Executive dies, retires,
or otherwise has a termination of employment with the Company that constitutes a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions
available thereunder. 
 5. Successors; Binding Agreement. 

(a) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company, to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
Failure of the Company to obtain such assumption and agreement prior to the effectiveness of any such succession shall be a breach of this Agreement and shall entitle the Executive to compensation from the Company in the same amount and on the same
terms as he would be entitled to hereunder if he terminated his employment for Good Reason, except that for purposes of implementing the foregoing, the date on which any such succession becomes effective shall be deemed the date of termination. As
used in this Agreement, “Company” shall mean the Company as herein before defined and any successor to its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Section 5 or which otherwise
becomes bound by all the terms and provisions of this Agreement by operation of law. 
 (b) This Agreement and all rights
of the Executive hereunder shall inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrator, successors, heirs, distributees, devisees and legatees. If the Executive should die
while any amounts would still be payable to him hereunder if he had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the Executive’s devisee, legatee, or
other designee or, if there be no such designee, to the Executive’s estate. 
 6. Notices. For the purposes of
this Agreement, notices, demands and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered personally, by telecopy, email or other form of written electronic

  
 6 

 
transmission, by overnight courier or by registered or certified mail, postage prepaid, or mailed by United States certified or registered mail, return receipt requested, postage prepaid,
addressed as follows: 
 If to the Executive: 
 Daniel J. Starck 
 19 Pegasus Drive 

Coto de Caza, CA 92679-4742 
 If to the Company: 
 Apria Healthcare Group Inc. 

26220 Enterprise Court 
 Lake Forest, California 92630 
 Attention: Chief Executive Officer 

With a copy to the attention of the Company’s Executive Vice President, Human Resources or to such other address as either party may have furnished
to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt. 

7. Antisolicitation. The Executive promises and agrees that, during the period of his employment by the Company and for a
period of two years thereafter, he will not influence or attempt to influence customers or patients of the Company or any of its present or future subsidiaries or affiliates, either directly or indirectly, to divert their business to any individual,
partnership, firm, corporation or other entity then in competition with the business of the Company, or any subsidiary or affiliate of the Company, where the identity of the customer or patient, or any information concerning the relationship between
the customer or patient and the Company, is a trade secret or other Confidential Material (as defined below). 

8. Soliciting Employees. The Executive promises and agrees that, for a period of two years following termination of his
employment, he will not, directly or indirectly, solicit any of the Company employees who earned annually $50,000 or more as a Company employee during the last six months of his own employment, or facilitate the hiring of any such employee, to work
for any other business, individual, partnership, firm, corporation, or other entity. 
 9. Confidential Information.

 (a) The Executive, in the performance of his duties on behalf of the Company, shall have access to, receive and be
entrusted with confidential information, including but not limited to systems technology, field operations, reimbursement, development, marketing, organizational, financial, management, administrative, clinical, customer, distribution and sales
information, data, specifications and processes presently owned or at any time in the future developed, by the Company or its agents or consultants, or used presently or at any time in the future in the course of its business that is not otherwise
part of the public domain (collectively, the “Confidential Material”). All such Confidential Material is considered secret and will be available to the Executive in confidence. Except in the performance of duties on behalf of the Company,
the Executive shall not, directly or indirectly for any reason whatsoever, disclose or use any such Confidential Material, unless such Confidential Material ceases (through no fault of the 

  
 7 

 
Executive’s) to be confidential because it has become part of the public domain. All records, files, drawings, documents, notes, disks, diskettes, tapes, magnetic media, photographs,
equipment and other tangible items, wherever located, relating in any way to the Confidential Material or otherwise to the Company’s business, which the Executive prepares, uses or encounters during the course of his employment, shall be and
remain the Company’s sole and exclusive property and shall be included in the Confidential Material. Upon termination of this Agreement by any means, or whenever requested by the Company, the Executive shall promptly deliver to the Company any
and all of the Confidential Material, not previously delivered to the Company, that may be or at any previous time has been in the Executive’s possession or under the Executive’s control. 

(b) The Executive hereby acknowledges that the sale or unauthorized use or disclosure of any of the Company’s Confidential
Material by any means whatsoever and at any time before, during or after the Executive’s employment with the Company shall constitute unfair competition. The Executive agrees he shall not engage in unfair competition either during the time
employed by the Company or any time thereafter. 
 (c) The Executive promises and agrees that for a period of one year
following termination of his employment, he will not, other than as required by law or by order of a court or other competent authority, make or publish, or cause any other person to make or publish, any statement that is disparaging or that
reflects negatively upon the Company, or that is or reasonably would be expected to be damaging to the reputation of the Company. The Company promises and agrees that it will use its best efforts to not, other than as required by law or by order of
a court or other competent authority, make or publish, or cause any other person to make or publish, any statement that is disparaging or that reflects negatively upon the Executive, or that is or reasonably would be expected to be damaging to the
reputation of the Executive. 
 10. Parachute Limitation. 

 

	 	(i)	 Notwithstanding any other provision of this Agreement, in the event that any amount or benefit that may be paid or otherwise provided to or in respect
of the Executive by or on behalf of the Company or any affiliate, whether pursuant to this Agreement or otherwise (collectively, “Covered Payments”), is or may become subject to the tax imposed under Section 4999 of the Internal
Revenue Code of 1986, as amended (the “Code”) (or any successor provision or any comparable provision of state, local or foreign law) (“Excise Tax”), then the portion of the Covered Payments that would be treated as
“parachute payments” under Code Section 280G (“Covered Parachute Payments”) shall be reduced so that the Covered Parachute Payments, in the aggregate, are reduced to the Safe Harbor Amount (as defined below); provided that
such reduction to the Covered Payments shall be made only if the total after-tax benefit to the Executive is greater after giving effect to such reduction than if no such reduction had been made. For purposes of this Agreement, the term “Safe
Harbor Amount” means the largest portion of the Covered Payments that would result in no portion of the Covered Payments being subject to the Excise Tax. In the event that it is determined that the amount of any Covered Payments will be reduced
in accordance with this Section 10, the Covered Payments shall be reduced on a nondiscretionary basis in such a way as to minimize the reduction in the 

  
 8 

	 	
economic value deliverable to the Executive. Where more than one payment has the same value for this purpose and they are payable at different times they will be reduced on a pro rata basis.

  

	 	(ii)	The determination of (i) whether an event described in Section 280G(b)(2)(A)(i) of the Code has occurred, (ii) the value of any Covered Parachute
Payments and the Safe Harbor Amount, (iii) whether any reduction in the Covered Payments is required under Section 10(a), and (iv) the amount of any such reduction, shall be made initially by an accounting firm selected by the Board
or, if no such firm is selected, by the independent compensation consulting firm retained by the Board to provide consulting advice to the Board (the “Accountants”). For purposes of making the calculations required by this Section 10,
the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the Code, and other applicable legal authority. The Company and the
Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 10. The Company shall bear and be solely responsible for all costs the
Accountants may reasonably incur in connection with any calculations contemplated by this Section 10. 

  

	 	(iii)	If it is determined that a reduction in payments is required pursuant to Section 10(a) and, notwithstanding any prior reduction described in this Section 10,
the Internal Revenue Service (the “IRS”) determines that the Executive is liable for the Excise Tax as a result of the receipt of amounts payable under this Agreement or otherwise as described above, then the Executive shall be obligated
to pay back to the Company, within thirty (30) days after a final IRS determination or in the event that the Executive challenges the final IRS determination, a final judicial determination, a portion of such amounts equal to the
“Repayment Amount”. The Repayment Amount with respect to the payment of benefits shall be, if a reduction in payments is required pursuant to Section 10(a), the smallest such amount as shall be required to be paid to the Company so
that the Executive is not subject to the Excise Tax. 

 11. Section 409A. 

(a) It is intended that any amounts payable under this Agreement and the Company’s and the Executive’s exercise of
authority or discretion hereunder shall comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) (“Section 409A”) so as not to subject the Executive to payment of
any interest or additional tax imposed under Section 409A. To the extent that any amount payable under this Agreement would trigger the additional tax imposed by Section 409A, the Agreement shall be construed and interpreted in a manner to
avoid such additional tax yet preserve (to the nearest extent reasonably possible) the intended benefit payable to the Executive. 
 (b) Notwithstanding any provision of this Agreement to the contrary, if the Executive is a “specified employee” within the meaning of Treasury Regulation Section 1.409A-1(i) as of the
date of the Executive’s Separation from Service, and if the deferral of the commencement of 

  
 9 

 
any payments or benefits otherwise payable hereunder for a period of six (6) months following the Executive’s Separation from Service is necessary pursuant to Section 409A of the
Code, commencement of any such payments or benefits shall be delayed as required by Section 409A of the Code. Any amounts otherwise payable to the Executive upon or in the six (6) month period following the Executive’s Separation from
Service that are not so paid by reason of this Section 11(b) shall be paid as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after the Executive’s Separation from
Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of the Executive’s death). The provisions of this Section 11(b) shall only apply if, and to the extent, required to avoid the
imputation of any tax, penalty or interest pursuant to Section 409A of the Code. 
 (c) Except as otherwise explicitly
provided herein, any reimbursements or in-kind benefits provided hereunder shall be made or provided in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement
is for expenses incurred during the period of time specified in this Agreement (or, if no such period is specified, the Executive’s lifetime), (ii) the amount of expenses eligible for reimbursement, or in kind benefits provided, during a
calendar year may not affect the expenses eligible for reimbursement, or in kind benefits to be provided, in any other calendar year, (iii) the reimbursement of an eligible expense will be made no later than the last day of the calendar year
following the year in which the expense is incurred, and (iv) the right to reimbursement or in kind benefits is not subject to liquidation or exchange for another benefit. In addition, any tax gross-up payments provided for herein shall be paid
as soon as practicable, but in no event later than the end of the Executive’s taxable year following the Executive’s taxable year in which he remits the related taxes. Notwithstanding any other provision contained herein, any offset
pursuant to the terms this Agreement of amounts payable to the Executive shall be in accordance with Section 409A of the Code. 
 12. Modification and Waiver. No provisions of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing signed by the Executive
and the Chief Executive Officer of the Company. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be
deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by
either party which are not set forth expressly in this Agreement. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California without regard to its conflicts of law
principles. 
 13. Severability. The provisions of this Agreement are severable and in the event that a court of
competent jurisdiction determines that any provision of this Agreement is in violation of any law or public policy, in whole or in part, only the portions of this Agreement that violate such law or public policy shall be stricken. All portions of
this Agreement that do not violate any statute or public policy shall not be affected thereby and shall continue in full force and effect. Further, any court order striking any portion of this Agreement shall modify the stricken terms as narrowly as
possible to give as much effect as possible to the intentions of the parties under this Agreement. 

  
 10 

 14. Counterparts. This Agreement may be executed in one or more counterparts,
each of which shall be deemed to be an original but all of which together will constitute one and the same instrument. 

15. Arbitration. Any dispute or controversy arising under or in connection with this Agreement or the Executive’s
employment by the Company shall be settled exclusively by arbitration, conducted before a single neutral arbitrator in accordance with the American Arbitration Association’s National Rules for Resolution of Employment Disputes as then in
effect. Judgment may be entered on the arbitrator’s award in any court having jurisdiction; provided, however, that the Company shall be entitled to seek a restraining order or injunction in any court of competent jurisdiction to prevent any
continuation of any violation of the provisions of Sections 7, 8 or 9 of this Agreement and the Executive hereby consents that such restraining order or injunction may be granted without the necessity of the Company’s posting any bond, and
provided, further, that the Executive shall be entitled to seek specific performance of his right to be paid until the date of employment termination during the pendency of any dispute or controversy arising under or in connection with this
Agreement. The Executive expressly acknowledges and agrees that if the Company has a reasonable good faith belief that he is in violation of any of the restrictive covenants set forth in said Sections 7, 8 or 9, then the Company, following
written notice to the Executive explaining the basis for its belief, may suspend any future payments scheduled to be made pursuant to Section 4, unless and until the Executive establishes to the Company’s reasonable good faith satisfaction
that no such violation has occurred. Each party shall pay its own attorneys’ fees and costs. If any party prevails on a statutory claim which affords attorneys’ fees and costs, the arbitrator may award reasonable attorneys’ fees
and/or costs to the prevailing party. The fees and expenses of the arbitrator and the arbitration shall be borne by the Company. 
 16. Entire Agreement. This Agreement, together with the exhibits attached hereto, sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and
supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party hereto; and any prior agreement of the parties hereto
in respect of the subject matter contained herein is hereby terminated and canceled. 

  
 11 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first
above written. 
  

			
	APRIA HEALTHCARE GROUP INC.
		
	By:	 	  

	Name:	 	Norman C. Payson, M.D.
	Title:	 	Chief Executive Officer
	
	EXECUTIVE
		
	By:	 	  

		 	Name: Daniel J. Starck

  
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]